Skip to content

A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe.

Raphaël Serreau, Ammar Amirouche, Amine Benyamina, Sabine Berteina-Raboin

Pharmaceuticals (Basel, Switzerland) December 28, 2022 DOI: 10.3390/ph16010040 via PubMed

Summary

AI-generated from the abstract

Psychedelic compounds found in Psilocybe mushrooms are being studied for treating central nervous system disorders, but obtaining enough pure material from fungi for research is challenging. This review examines synthetic chemistry methods to produce these molecules, covering classic historical syntheses, modern metal-catalyzed coupling reactions, and biocatalytic approaches. The authors note that alternative synthetic routes will likely be needed as therapeutic interest in these compounds grows.

Study at a glance

Characteristics Review Peer reviewed
Topics Psilocybin Psychedelic-assisted therapy
Keywords Psilocybe mushrooms Clinical research Synthetic access
Citations 13
Key finding Multiple synthetic routes exist for producing psilocybin and related compounds, including historical methods, metal-catalyzed couplings, and biocatalysis, but further development is needed to meet research demands.

Abstract

Psychedelics are used for various pathologies of the central nervous system and are currently the subject of much research, some of which relates to the compounds contained in various Psilocybe-type hallucinogenic mushrooms. It is difficult, however, to obtain and purify sufficient quantities of these compounds from fungi to carry out biological studies, hence the need to develop simple and efficient synthetic routes. We review here the various syntheses used to obtain these molecules, focusing first on the classic historical syntheses, then the use of more recent metallo-catalyzed couplings and finally the known biocatalytic methods for obtaining these molecules. Other access routes are certainly possible and should be the subject of future research given the therapeutic interest of these compounds.

Explore topics

Comments

No comments yet.

Log in to comment